Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Alongi

Showing results (1-10 of 305) with videos related to

Pageof 31
Sort By:
Cancers|February 10, 2024
Radiotherapy of Oligometastatic CancersFilippo Alongi, Simona Gaito
Critical Reviews in Oncology/Hematology|January 20, 2012
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A reviewStefano Arcangeli, Marta Scorsetti, Filippo Alongi
Critical Reviews in Oncology/Hematology|March 31, 2015
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literatureBerardino De Bari, Antonino Daidone, Filippo Alongi
Cancer Investigation|January 27, 2016
What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A reviewNiccoló Giaj-Levra, Francesco Ricchetti, Filippo Alongi
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|December 24, 2015
SBRT and extreme hypofractionation: A new era in prostate cancer treatments?Filippo Alongi, Alba Fiorentino, Berardino De Bari
Tumori|May 2, 2018
Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteriaFilippo Alongi, Rosario Mazzola, Vanessa Figlia, et al.
Annals of Translational Medicine|March 5, 2015
Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?Luca Bertolaccini, Alberto Terzi, Francesco Ricchetti, et al.
Tumori|October 14, 2006
Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancerFilippo Alongi, Pietro Ragusa, Paolo Montemaggi, et al.
Critical Reviews in Oncology/Hematology|May 13, 2014
Choline-PET in prostate cancer management: the point of view of the radiation oncologistBerardino De Bari, Filippo Alongi, Laëtitia Lestrade, et al.
Critical Reviews in Oncology/Hematology|September 17, 2015
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer?Stefano Arcangeli, Thomas Zilli, Berardino De Bari, et al.
Pageof 31

Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Cancers|February 10, 2024
Radiotherapy of Oligometastatic CancersFilippo Alongi, Simona Gaito
Critical Reviews in Oncology/Hematology|January 20, 2012
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A reviewStefano Arcangeli, Marta Scorsetti, Filippo Alongi
Critical Reviews in Oncology/Hematology|March 31, 2015
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literatureBerardino De Bari, Antonino Daidone, Filippo Alongi
Cancer Investigation|January 27, 2016
What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A reviewNiccoló Giaj-Levra, Francesco Ricchetti, Filippo Alongi
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|December 24, 2015
SBRT and extreme hypofractionation: A new era in prostate cancer treatments?Filippo Alongi, Alba Fiorentino, Berardino De Bari
Tumori|May 2, 2018
Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteriaFilippo Alongi, Rosario Mazzola, Vanessa Figlia, et al.
Annals of Translational Medicine|March 5, 2015
Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?Luca Bertolaccini, Alberto Terzi, Francesco Ricchetti, et al.
Tumori|October 14, 2006
Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancerFilippo Alongi, Pietro Ragusa, Paolo Montemaggi, et al.
Critical Reviews in Oncology/Hematology|May 13, 2014
Choline-PET in prostate cancer management: the point of view of the radiation oncologistBerardino De Bari, Filippo Alongi, Laëtitia Lestrade, et al.
Critical Reviews in Oncology/Hematology|September 17, 2015
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer?Stefano Arcangeli, Thomas Zilli, Berardino De Bari, et al.
Pageof 31